Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)

Clinical trial NCT04776447 · COMPLETED

Trial details

NCT number: NCT04776447
Sponsor: Fundación GECP
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Diseases Carcinoma, Non-Small-Cell Lung Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Respiratory Tract Neoplasms Carcinoma Bronchiogenic Stage III Thoracic Neoplasms

Start date: 2021-06-16
Primary completion: 2025-01-15
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.